# AMEVIVE® Pregnancy Registry

> **NCT00342862** · — · TERMINATED · sponsor: **Astellas Pharma Inc** · enrollment: 3 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DRUG:** Amevive exposure

## Key facts

- **NCT ID:** NCT00342862
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2003-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing, distribution and sales of Amevive
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00342862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00342862, "AMEVIVE® Pregnancy Registry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00342862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*